Intravascular Catheterization Global Market Report 2025

The intravascular catheterization market size has grown strongly in recent years. It will grow from $12.72 billion in 2024 to $13.64 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth during the historic period can be attributed to the rise in cardiovascular disease cases, an increase in hospital admissions, the expanding elderly population, the growing adoption of minimally invasive procedures, and the rising prevalence of chronic diseases.

The intravascular catheterization market size is expected to see strong growth in the next few years. It will grow to $17.87 billion in 2029 at a compound annual growth rate (CAGR) of 7%. The growth in the forecast period can be attributed to the expansion of outpatient care facilities, an increase in the number of catheterization laboratories, rising demand for advanced catheter technologies, a growing number of regulatory approvals, and heightened awareness of catheterization procedures. Key trends expected during this period include innovations in antimicrobial catheter coatings, the integration of artificial intelligence for real-time imaging support, the emergence of smart catheters equipped with sensors, advancements in ultrasound-assisted catheter placement techniques, and progress in the development of biocompatible catheter materials.

The growing prevalence of cardiovascular disorders is expected to drive the expansion of the intravascular catheterization market in the coming years. Cardiovascular disorders encompass a variety of conditions affecting the heart and blood vessels, including heart disease, stroke, and hypertension. The rise in these conditions is primarily linked to increasing obesity rates, which elevate the risk of associated health issues such as high blood pressure and diabetes - key contributors to heart disease. Intravascular catheterization plays a crucial role in managing cardiovascular disorders by enabling minimally invasive diagnostic and therapeutic procedures, such as coronary angiography, angioplasty, and stent placement, to restore proper blood flow. For example, in January 2025, the American Heart Association - a U.S.-based nonprofit - reported that cardiovascular disease (CVD)-related deaths in the United States rose to 941,652 in 2022, up from 931,578 in 2021. Thus, the rising incidence of cardiovascular conditions is a key factor fueling the growth of the intravascular catheterization market.

Leading companies in the intravascular catheterization market are prioritizing the development of advanced technologies, such as AI-powered intravascular ultrasound (IVUS) systems, to improve imaging accuracy and optimize clinical workflows. AI-powered IVUS systems are cutting-edge medical imaging tools that integrate traditional intravascular ultrasound with artificial intelligence algorithms to enhance diagnostic precision, efficiency, and image interpretation during cardiovascular interventions. For example, in October 2023, Evident Vascular Inc., a U.S.-based medical technology firm, introduced an AI-enabled IVUS platform designed to deliver high-resolution images from within blood vessels. This technology is intended for evaluating vascular diseases and guiding interventional treatments. The catheter-based ultrasound system utilizes AI to boost image clarity, assist in interpretation, and streamline procedures for healthcare providers, initially targeting peripheral vascular interventions, with future plans to expand into coronary applications.

In April 2025, Boston Scientific Corporation, a U.S.-based leader in minimally invasive cardiovascular devices, acquired Bolt Medical for $443 million. This strategic acquisition is intended to enhance Boston Scientific’s cardiovascular portfolio by adding next-generation intravascular lithotripsy (IVL) technology, enabling improved treatment of complex calcified arterial disease and reinforcing the company’s position in minimally invasive interventional cardiology. Bolt Medical is a U.S.-based medical technology firm specializing in the development of innovative laser-based intravascular lithotripsy (IVL) catheters.

Major players in the intravascular catheterization market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic plc, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, Edwards Lifesciences Corporation, Nipro Corporation, Teleflex Incorporated, Cook Medical LLC, ICU Medical Inc., Smiths Medical, Merit Medical Systems Inc., Penumbra Inc., Vygon SA, AngioDynamics Inc., ACIST Medical Systems Inc., C. R. Bard Inc., and Shanghai Kindly Enterprise Development Group Co. Ltd.

North America was the largest region in the intravascular catheterization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in intravascular catheterization report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the intravascular catheterization market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Intravascular catheterization refers to the process of inserting a catheter into a blood vessel to enable the delivery of medications or fluids, or for monitoring vital physiological parameters. This procedure is widely used in clinical settings to ensure direct access to the bloodstream for therapeutic or diagnostic purposes.

The primary types of intravascular catheterization include centrally inserted catheters, peripherally inserted central catheters (PICC), peripheral catheters, and dialysis catheters. Centrally inserted catheters are designed for long-term use and are placed into major central veins, such as the subclavian or jugular veins. These catheters are manufactured using various materials, including polyurethane, silicone, polyvinyl chloride (PVC), and others, and are utilized in diverse procedures including elective surgeries, emergency care, interventional radiology, and cardiac interventions. Their applications span across fields such as oncology, cardiology, pediatrics, and infection control, serving end users including hospitals, ambulatory surgical centers (ASCs), home healthcare providers, and research laboratories.

The intravascular catheterization market research report is one of a series of new reports that provides intravascular catheterization market statistics, including intravascular catheterization industry global market size, regional shares, competitors with an intravascular catheterization market share, detailed intravascular catheterization market segments, market trends and opportunities, and any further data you may need to thrive in the intravascular catheterization industry. This intravascular catheterization market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intravascular catheterization market includes revenues earned by entities by providing services such as coronary angiography, percutaneous coronary intervention, dialysis catheter insertion, and neurological applications. The market value includes the value of related goods sold by the service provider or included within the service offering. The intravascular catheterization market also consists of sales of vascular access catheters, guiding catheters, introducer sheaths, hemodialysis catheters, and balloon catheters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.